Updates are available Correction dated 2022-05-10
Click to view Correction: https://doi.org/10.1007/s10555-022-10037-3
-
Authors
Sexton, Rachel E.
Uddin, Md Hafiz
Bannoura, Sahar
Khan, Husain Yar
Mzannar, Yousef
Li, Yiwei
Aboukameel, Amro
Al-Hallak, Mohammad Najeeb
Al-Share, Bayan
Mohamed, Amr
Nagasaka, Misako
El-Rayes, Bassel
Azmi, Asfar S.
-
Funding
Funding for this research was provided by:
DOD Peer Reviewed Cancer Research Program (CA191011)
National Institutes of Health (R37CA215427)
Sky Foundation
Perri Family Foundation
National Cancer Institute (R01CA240607)
- License Information
-
More Information
Article History
Received: 2 January 2022
Accepted: 2 March 2022
First Online: 2 April 2022
Change Date: 10 May 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10555-022-10037-3
Declarations
:
: ASA received funding from Karyopharm, EISAI, Jannsen and Rhizen. ASA received speaker fees from Karyopharm Therapeutics Inc. ASA is a council member at GLG and Guidepoint.
Free to read: This content has been made available to all.
